deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT03252522

Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study (MADDY)

Evaluating the Efficacy of Supplementation With Micronutrients for ADHD in Youth (MADDY) Study

Sponsor: Foundation for Excellence in Mental Health Care

Conditions Attention Deficit Hyperactivity Disorder
Interventions Broad Spectrum Micronutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants Placebo
Updated 12 times since 2017 Last updated: Jan 11, 2023 Started: Apr 23, 2018 Primary completion: Jul 10, 2020 Completion: May 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Attention Deficit Hyperactivity Disorder and is currently completed. Foundation for Excellence in Mental Health Care leads this study, which shows 12 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotNot Yet Recruiting~Nov 2018 – ~Mar 2020 · 16 months · monthly snapshotRecruiting~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotActive Not Recruiting~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshotActive Not Recruiting~Sep 2021 – ~Mar 2022 · 6 months · monthly snapshotCompleted~Mar 2022 – ~Mar 2023 · 12 months · monthly snapshotCompleted~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotCompleted~Feb 2025 – present · 17 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Feb 2025 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Sep 2024 — Feb 2025 [monthly]

    Completed PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Mar 2023 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  5. Mar 2022 — Mar 2023 [monthly]

    Completed PHASE1_PHASE2

▶ Show 7 earlier versions

  1. Sep 2021 — Mar 2022 [monthly]

    Completed PHASE1_PHASE2

    Status: Active Not Recruiting → Completed

  2. Apr 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  3. Jan 2021 — Apr 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  4. Mar 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Nov 2018 — Mar 2020 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet Recruiting → Recruiting · Phase: PHASE4 → PHASE1_PHASE2

  6. Jun 2018 — Nov 2018 [monthly]

    Not Yet Recruiting PHASE4

  7. Sep 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Foundation for Excellence in Mental Health Care
  • National University of Natural Medicine
  • Ohio State University
  • Oregon Health and Science University
  • The Waterloo Foundation
  • University of Lethbridge
Data source: Oregon Health and Science University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations